(INVE-A) Investor ser. - Ratings and Ratios
Private Equity, Financial Services, Health Care, IT, Fintech
INVE-A EPS (Earnings per Share)
INVE-A Revenue
Description: INVE-A Investor ser.
Investor AB (publ) is a private equity firm that specializes in mature, middle-market buyouts and growth capital investments, focusing on healthcare, financial services, IT, and fintech sectors. The firm invests globally, with a preference for medium-sized to large companies headquartered in Northern Europe.
Key investment characteristics include: majority or minority stakes in listed and unlisted companies, investment sizes between SEK 20 million and SEK 200 million, and a holding period of 3-7 years for private equity investments. The firm also seeks to take board memberships in portfolio companies, indicating an active ownership approach.
From a financial perspective, Investor AB has a market capitalization of approximately SEK 869.4 billion. The companys Return on Equity (RoE) is 5.22%, indicating a relatively modest return on shareholder equity. The Price-to-Earnings (P/E) ratio is 20.00, suggesting a moderate valuation relative to earnings.
To further analyze Investor ABs performance, additional KPIs could be considered, such as: - Debt-to-Equity ratio to assess the companys leverage and financial health - Dividend yield to evaluate the return on investment for shareholders - Net Asset Value (NAV) per share to compare the companys market price to its underlying asset value - Investment portfolio diversification to assess the companys risk management These metrics would provide a more comprehensive understanding of Investor ABs financial situation and investment strategy.
INVE-A Stock Overview
| Market Cap in USD | 93,679m |
| Sub-Industry | Environmental & Facilities Services |
| IPO / Inception |
INVE-A Stock Ratings
| Growth Rating | 38.6% |
| Fundamental | 45.6% |
| Dividend Rating | 22.7% |
| Return 12m vs S&P 500 | -15.9% |
| Analyst Rating | - |
INVE-A Dividends
| Dividend Yield 12m | 1.68% |
| Yield on Cost 5y | 4.08% |
| Annual Growth 5y | -21.64% |
| Payout Consistency | 91.0% |
| Payout Ratio | 65.0% |
INVE-A Growth Ratios
| Growth Correlation 3m | 76.1% |
| Growth Correlation 12m | -47.9% |
| Growth Correlation 5y | 89.7% |
| CAGR 5y | 19.40% |
| CAGR/Max DD 5y | 0.66 |
| Sharpe Ratio 12m | 0.22 |
| Alpha | -14.59 |
| Beta | 0.716 |
| Volatility | 16.07% |
| Current Volume | 88.4k |
| Average Volume 20d | 128.4k |
| Stop Loss | 284.8 (-3%) |
| Signal | -2.19 |
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (23.36b TTM) > 0 and > 6% of Revenue (6% = 4.89b TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -0.04pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 60.37% (prev 24.26%; Δ 36.11pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 24.28b > Net Income 23.36b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 9.56 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (3.06b) change vs 12m ago -0.03% (target <= -2.0% for YES) |
| Gross Margin 72.67% (prev 71.86%; Δ 0.81pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 8.35% (prev 12.26%; Δ -3.91pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -2.63 (EBITDA TTM -16.95b / Interest Expense TTM 6.80b) >= 6 (WARN >= 3) |
Altman Z'' 2.83
| (A) 0.05 = (Total Current Assets 54.93b - Total Current Liabilities 5.74b) / Total Assets 985.32b |
| (B) 0.79 = Retained Earnings (Balance) 782.84b / Total Assets 985.32b |
| (C) -0.02 = EBIT TTM -17.89b / Avg Total Assets 975.27b |
| (D) 0.03 = Book Value of Equity 4.79b / Total Liabilities 145.01b |
| Total Rating: 2.83 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 45.57
| 1. Piotroski 2.50pt = -2.50 |
| 2. FCF Yield 1.96% = 0.98 |
| 3. FCF Margin 24.15% = 6.04 |
| 4. Debt/Equity 0.18 = 2.48 |
| 5. Debt/Ebitda -8.81 = -2.50 |
| 6. ROIC - WACC -9.55% = -11.94 |
| 7. RoE 2.82% = 0.23 |
| 8. Rev. Trend -30.94% = -1.55 |
| 9. Rev. CAGR 49.30% = 2.50 |
| 10. EPS Trend -27.26% = -0.68 |
| 11. EPS CAGR 84.81% = 2.50 |
What is the price of INVE-A shares?
Over the past week, the price has changed by -0.07%, over one month by +1.03%, over three months by +3.56% and over the past year by -1.03%.
Is Investor ser. a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of INVE-A is around 305.62 SEK . This means that INVE-A is currently overvalued and has a potential downside of 4.06%.
Is INVE-A a buy, sell or hold?
What are the forecasts/targets for the INVE-A price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 304 | 3.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 338.1 | 15.1% |
INVE-A Fundamental Data Overview
Market Cap SEK = 892.18b (892.18b SEK * 1.0 SEK.SEK)
CCE Cash And Equivalents = 37.47b SEK (Cash And Short Term Investments, last quarter)
P/E Trailing = 38.1152
P/S = 10.4754
P/B = 1.0556
Beta = 0.772
Revenue TTM = 81.47b SEK
EBIT TTM = -17.89b SEK
EBITDA TTM = -16.95b SEK
Long Term Debt = 145.01b SEK (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 4.43b SEK (from shortTermDebt, last fiscal year)
Debt = 149.45b SEK (Calculated: Short Term 4.43b + Long Term 145.01b)
Net Debt = 72.71b SEK (from netDebt column, last quarter)
Enterprise Value = 1004.16b SEK (892.18b + Debt 149.45b - CCE 37.47b)
Interest Coverage Ratio = -2.63 (Ebit TTM -17.89b / Interest Expense TTM 6.80b)
FCF Yield = 1.96% (FCF TTM 19.68b / Enterprise Value 1004.16b)
FCF Margin = 24.15% (FCF TTM 19.68b / Revenue TTM 81.47b)
Net Margin = 28.68% (Net Income TTM 23.36b / Revenue TTM 81.47b)
Gross Margin = 72.67% ((Revenue TTM 81.47b - Cost of Revenue TTM 22.27b) / Revenue TTM)
Tobins Q-Ratio = 209.4 (set to none) (Enterprise Value 1004.16b / Book Value Of Equity 4.79b)
Interest Expense / Debt = 1.56% (Interest Expense 2.33b / Debt 149.45b)
Taxrate = 1.06% (from yearly Income Tax Expense: 1.22b / 114.39b)
NOPAT = -17.89b (EBIT -17.89b, no tax applied on loss)
Current Ratio = 9.56 (Total Current Assets 54.93b / Total Current Liabilities 5.74b)
Debt / Equity = 0.18 (Debt 149.45b / last Quarter total Stockholder Equity 839.99b)
Debt / EBITDA = -8.81 (Net Debt 72.71b / EBITDA -16.95b)
Debt / FCF = 7.59 (Debt 149.45b / FCF TTM 19.68b)
Total Stockholder Equity = 829.45b (last 4 quarters mean)
RoA = 2.37% (Net Income 23.36b, Total Assets 985.32b )
RoE = 2.82% (Net Income TTM 23.36b / Total Stockholder Equity 829.45b)
RoCE = -1.84% (Ebit -17.89b / (Equity 829.45b + L.T.Debt 145.01b))
RoIC = -1.92% (NOPAT -17.89b / Invested Capital 931.46b)
WACC = 7.63% (E(892.18b)/V(1041.63b) * Re(8.65%)) + (D(149.45b)/V(1041.63b) * Rd(1.56%) * (1-Tc(0.01)))
Shares Correlation 5-Years: -20.0 | Cagr: 0.01%
Discount Rate = 8.65% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 67.76% ; FCFE base≈19.68b ; Y1≈12.92b ; Y5≈5.91b
Fair Price DCF = 84.22 (DCF Value 105.01b / Shares Outstanding 1.25b; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: -30.94 | Revenue CAGR: 49.30%
Rev Growth-of-Growth: 57.37
EPS Correlation: -27.26 | EPS CAGR: 84.81%
EPS Growth-of-Growth: -27.09